Clinical Trials Logo

Clinical Trial Summary

This study is to test whether a chlorine dioxide gas-generating device, which releases a low concentration gas of chlorine dioxide in a sustained manner, can protect against respiratory infections in elderly individuals living in nursing homes. Such a device is used as a deodorant for normal domestic purposes. The investigators reasoned that the antiviral and antibacterial properties of chlorine dioxide might lead to a lowering in the incidence of respiratory infectious diseases. The study is designed as a randomized placebo-controlled double-blind crossover multicentre trial involving approximately 1500 subjects.


Clinical Trial Description

Chlorine dioxide (ClO2), which is used as household deodorant, is a volatile gas that displays very strong oxidative activity. Indeed, the powerful oxidative activity of chlorine dioxide (Ogata, N., Biochemistry 46, 4898-4911, 2007) is responsible for its antimicrobial activity against bacteria (Benarde, M. A., et al. Appl. Mircrobiol. 15, 257-265, 1967), fungi (Morino, H., et al. Yakugaku Zasshi 127, 773-777, 2007) and viruses (Ogata, N. and Shibata, T. J. Gen. Virol. 89, 60-67, 2008). Recently, we found that the rate of absenteeism due to illness in a school was lower in classrooms where a chlorine dioxide gas-generating device was placed than in classrooms with no such device. Based upon this unexpected observation we hypothesize that chlorine dioxide gas, at a concentration low enough not to harm humans, may lower the incidence of respiratory infections by inactivating airborne microorganism within an enclosed space. ;


Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Crossover Assignment, Masking: Double Blind (Subject, Caregiver, Investigator), Primary Purpose: Prevention


Related Conditions & MeSH terms


NCT number NCT00969800
Study type Interventional
Source Taiko Pharmaceutical Co., Ltd.
Contact
Status Active, not recruiting
Phase N/A
Start date October 2009
Completion date April 2010

See also
  Status Clinical Trial Phase
Recruiting NCT05359770 - Association of Inspiratory Muscle Training With HD-tDCS for Assistance to Patients With Long Covid-19 N/A
Recruiting NCT02989051 - Fluid Restriction Keeps Children Dry Phase 2/Phase 3
Withdrawn NCT00800696 - Preventive Oral Care N/A
Completed NCT01009619 - Azithromycin in Bronchiolitis Obliterans Syndrome Phase 4
Completed NCT04102644 - Limiting Adverse Birth Outcomes in Resource-Limited Settings
Not yet recruiting NCT05047666 - COVID-Like Illness Respiratory Pathogens. A Prospective Cohort on the COVID-19 Post-acute Condition
Completed NCT05683951 - Clinical Trial to Evaluate the Efficacy and Safety of DWKH Phase 3
Withdrawn NCT02981550 - Infection Detection by Breath Analysis N/A
Completed NCT03064659 - Driving Pressure And EFL in Adult Cardiac Surgery N/A
Recruiting NCT05860387 - Early Diagnosis of Invasive Lung Aspergillosis
Completed NCT03726853 - The Clinical Trial to Evaluate the Efficacy and Safety of CKD-497 Phase 2
Completed NCT01102374 - Vitamin D Supplementation and Acute Respiratory Infection in Older Long-Term Care Residents Phase 2
Completed NCT00758914 - Vitamin E and Infection in the Elderly N/A
Recruiting NCT05904223 - Effect of IN Hospital PCR Based Assessment of Patients With Lower Respiratory Tract Infections on LEngth of Stay N/A
Recruiting NCT06390878 - Nationwide Research on the Rewilding of Kindergarten Yards N/A
Completed NCT03540706 - Impact of the Use of CRP on the Prescription of Antibiotics in General Practitioners N/A
Completed NCT04318691 - Netosis in Determination of Respiratory Infection Severity
Recruiting NCT04581486 - Effectiveness of an Optimal-Massive Intervention in Older Patients With Dysphagia N/A
Completed NCT01967628 - Human Lung Responses to Respiratory Pathogens Phase 1/Phase 2
Completed NCT00967551 - Micronutrient Sprinkles in a Daycare Center Phase 3